Crescentic IgA nephropathy in a child: Effect of a new combination therapy

Mitsuhiro Okamoto; Naoki Yokoyama; Kandai Nozu; Koichi Nakanishi; Norishige Yoshikawa

doi:10.1111/ped.13225

Crescentic IgA nephropathy in a child: Effect of a new combination therapy

Pediatr Int. 2017 Apr;59(4):501-503. doi: 10.1111/ped.13225. Epub 2017 Feb 28.

Authors

Mitsuhiro Okamoto¹, Naoki Yokoyama¹, Kandai Nozu², Koichi Nakanishi³, Norishige Yoshikawa^{1

4}

Affiliations

¹ Department of Pediatrics, Akashi Medical Center, Akashi, Japan.
² Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
³ Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
⁴ Clinical Research Center, Wakayama Medical University, Wakayama, Japan.

PMID: 28244692
DOI: 10.1111/ped.13225

No abstract available

Keywords: angiotensin II receptor blocker; angiotensin-converting enzyme inhibitor; combination therapy; crescentic IgA nephropathy; diffuse mesangial proliferation.

Publication types

Case Reports

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Anti-Inflammatory Agents / therapeutic use
Child
Drug Therapy, Combination
Glomerulonephritis, IGA / diagnosis
Glomerulonephritis, IGA / drug therapy*
Humans
Lisinopril / therapeutic use*
Male
Prednisolone / therapeutic use*
Ribonucleosides / therapeutic use*
Valsartan / therapeutic use*

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Inflammatory Agents
Ribonucleosides
mizoribine
Valsartan
Prednisolone
Lisinopril